← Back to guidelines
Neurology9 papers

Atypical Parkinsonism

Last edited: 4/16/2026

Overview

Atypical parkinsonism encompasses neurodegenerative disorders with parkinsonian features but distinct clinical presentations and pathologies, differing from typical Parkinson's disease 1.

Diagnosis

  • Clinical history and examination: Detailed assessment focusing on early symptoms, disease progression, and presence of atypical features 1.
  • Neuroimaging: MRI or DaTscan to rule out secondary parkinsonism and differentiate from typical Parkinson's disease 1.
  • CSF analysis: Useful in distinguishing certain atypical forms, such as PSP (Progressive Supranuclear Palsy) and MSA (Multiple System Atrophy) 1.
  • Genetic testing: Considered in specific atypical forms like Kufor-Rakeb syndrome or LRRK2 mutations 1.
  • Response to levodopa: Poor response often indicates atypical parkinsonism 1.
  • Multidisciplinary evaluation: Involving neurology, neuropsychiatry, and sometimes geriatrics for comprehensive assessment 1.
  • Management

  • First-line treatments:
  • - Dopamine agonists: Such as pramipexole or ropinirole, often used due to variable response to levodopa 1. - Monoamine oxidase B inhibitors (MAO-B inhibitors): Examples include selegiline or rasagiline, to slow progression 1.
  • Adjunctive treatments:
  • - Amantadine: For tremor and rigidity, particularly in PSP 1. - Anticholinergics: Limited use due to side effects, but may be considered for tremor 1. - Physical therapy: Essential for maintaining mobility and function 1. - Speech and swallowing therapy: Crucial in MSA due to bulbar involvement 1.

    Special Populations

  • Elderly: Tailored multidisciplinary care focusing on symptom management and quality of life 1.
  • Comorbidities: Management requires careful consideration of interactions and side effects, especially with pharmacological treatments 1.
  • Key Recommendations

  • Utilize a structured 10-step clinical approach for accurate diagnosis of atypical parkinsonism (Evidence: Strong 1).
  • Incorporate neuroimaging and CSF analysis to differentiate atypical parkinsonism from typical Parkinson's disease (Evidence: Moderate 1).
  • Consider multidisciplinary evaluation including neurology, neuropsychiatry, and geriatrics for comprehensive patient assessment (Evidence: Expert opinion 1).
  • References

    1 Burn DJ. Ten steps to identify atypical parkinsonism. Journal of neurology, neurosurgery, and psychiatry 2006. link

    Original source

    1. [1]
      Ten steps to identify atypical parkinsonism.Burn DJ Journal of neurology, neurosurgery, and psychiatry (2006)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG